Skip to main content

FOLD- Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
CEO1.02M$14.80M-
Other464.6K$6.73M-
Other409.3K$5.93M-
Other221.8K$3.21M-
CFO143.6K$2.08M-

Activity

Buys and sells only

Transactions

10 filings · page 20
DateInsiderRoleTypeSharesPriceValueChg%SEC
Sep 1, 2020Crowley John F67Chairman &CEOSale+OE29,900$14.18$423,850.44-3.4%
Aug 31, 2020Barth JayChief Medical OfficerSale+OE28,750$14.74$423,746.25-15.0%
Aug 17, 2020Crowley John F67Chairman &CEOSale+OE20,000$14.89$297,814.00-2.3%
Aug 5, 2020Prout Samantha68Principal Accounting OfficerSale+OE198$15.05$2,979.90-1.1%
Aug 3, 2020Crowley John F67Chairman &CEOSale+OE39,655$14.78$586,081.07-4.4%
Aug 3, 2020Campbell Bradley L66Chief Operating OfficerSale+OE10,000$14.78$147,779.00-2.9%
Aug 3, 2020Whitman Burke W50DirectorBuy1,500$14.53$21,795.00+4.8%
Jul 27, 2020Barth JayChief Medical OfficerSale+OE30,000$15.05$451,377.00-15.5%
Jul 16, 2020Rosenberg Ellen65Chief Legal OfficerSale+OE30,000$15.26$457,911.00-13.3%
Jul 15, 2020Crowley John F67Chairman &CEOSale+OE20,000$15.54$310,848.00-2.2%